Atrys Health SL (ATRY) - Total Assets
Based on the latest financial reports, Atrys Health SL (ATRY) holds total assets worth €494.04 Million EUR (≈ $577.59 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Atrys Health SL debt service capacity to assess how comfortably operating cash covers total debt obligations.
Atrys Health SL - Total Assets Trend (2012–2025)
This chart illustrates how Atrys Health SL's total assets have evolved over time, based on quarterly financial data. See ATRY net assets for net asset value and shareholders' equity analysis.
Atrys Health SL - Asset Composition Analysis
Current Asset Composition (December 2025)
Atrys Health SL's total assets of €494.04 Million consist of 47.4% current assets and 52.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 2.6% |
| Accounts Receivable | €29.46 Million | 6.0% |
| Inventory | €2.24 Million | 0.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €75.63 Million | 15.3% |
| Goodwill | €132.45 Million | 26.8% |
Asset Composition Trend (2012–2025)
This chart illustrates how Atrys Health SL's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Atrys Health SL market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Atrys Health SL's current assets represent 47.4% of total assets in 2025, an increase from 26.0% in 2012.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2025, up from 2.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 40.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 26.8% of total assets.
Atrys Health SL Competitors by Total Assets
Key competitors of Atrys Health SL based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Prostemics Co. Ltd
KQ:203690
|
Korea | ₩39.70 Billion |
|
ORUM
KQ:475830
|
Korea | ₩191.52 Billion |
|
TELIX Pharmaceuticals Ltd
AU:TLX
|
Australia | AU$1.19 Billion |
|
TG Therapeutics Inc
NASDAQ:TGTX
|
USA | $1.53 Billion |
|
Green Cross Holdings Preference Shares
KO:005257
|
Korea | ₩4.12 Trillion |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
|
USA | $285.41 Million |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5
|
Germany | €40.03 Million |
|
Cybin Inc
NEO:CYBN
|
Canada | CA$290.11 Million |
Atrys Health SL - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.81 | 0.89 | 1.74 |
| Quick Ratio | 0.80 | 0.88 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-56.46 Million | €-10.61 Million | €15.85 Million |
Atrys Health SL - Advanced Valuation Insights
This section examines the relationship between Atrys Health SL's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 0.41 |
| Asset Growth Rate (YoY) | -15.4% |
| Total Assets | €494.04 Million |
| Market Capitalization | $202.32 Million USD |
Valuation Analysis
Below Book Valuation: The market values Atrys Health SL's assets below their book value (0.41x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Atrys Health SL's assets decreased by 15.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Atrys Health SL (2012–2025)
The table below shows the annual total assets of Atrys Health SL from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €494.04 Million ≈ $577.59 Million |
-15.43% |
| 2024-12-31 | €584.19 Million ≈ $682.98 Million |
-7.12% |
| 2023-12-31 | €629.00 Million ≈ $735.37 Million |
-10.82% |
| 2022-12-31 | €705.28 Million ≈ $824.55 Million |
+24.69% |
| 2021-12-31 | €565.63 Million ≈ $661.28 Million |
+221.79% |
| 2020-12-31 | €175.78 Million ≈ $205.50 Million |
+99.65% |
| 2019-12-31 | €88.04 Million ≈ $102.93 Million |
+63.97% |
| 2018-12-31 | €53.69 Million ≈ $62.77 Million |
+33.58% |
| 2017-12-31 | €40.20 Million ≈ $46.99 Million |
+31.50% |
| 2016-12-31 | €30.57 Million ≈ $35.74 Million |
+17.14% |
| 2015-12-31 | €26.10 Million ≈ $30.51 Million |
+33.62% |
| 2014-12-31 | €19.53 Million ≈ $22.83 Million |
+3.49% |
| 2013-12-31 | €18.87 Million ≈ $22.06 Million |
+3.16% |
| 2012-12-31 | €18.29 Million ≈ $21.39 Million |
-- |
About Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of r… Read more